CAPR
Capricor Therapeutics
$6.23
+$0.13 (+2.13%)Oct 28, 2026
Key metrics
The numbers that frame CAPR today
- Market cap
- $362.21M
- ROIC
- -67.6%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $2.96
- 52wk High
- $40.37
Growth
Revenue and earnings trend for CAPR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about CAPR
Is Capricor Therapeutics a good buy?
No. Capricor Therapeutics has strong momentum, but poor quality undercuts the setup. Growth looks weak. That could put pressure on the long-term business case. We think Capricor Therapeutics is selling at a very high price.
What is the market capitalization of CAPR?
Capricor Therapeutics's market capitalization is $362.21M.
What is the 52-week high for CAPR stock?
The 52-week high for Capricor Therapeutics is $40.37. The current close of $6.23 is 84.6% below that high.
What is the 52-week low for CAPR stock?
The 52-week low for Capricor Therapeutics is $2.96. The current close of $6.23 is 110.5% above that low.
Does CAPR stock pay dividends?
Capricor Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CAPR?
Capricor Therapeutics's Debt / Equity ratio is 0.37.